Clinical Trial Update: Use of Biotene Moisturizing Mouth Spray for Xerostomia Associated With Oral Oxybutynin Use [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Biotene Moisturizing Mouth Spray for xerostomia associated with oral oxybutynin use has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Xerostomia

Drugs mentioned

• Biotene Moisturizing Mouth Spray (biotene mouth spray)
• oxybutynin (oxybutynin)

Snippet

Sponsor: University of Southern California | Conditions: Overactive Bladder, Xerostomia | Phase 4 | Status: WITHDRAWN